Click here to download the slides from this symposium. Thursday, September 18, 2014 12:00 PM - 5:00 PM Washington Marriot Wardman Park Hotel Room: Washington 4-5 Washington, DC Joint Provided/Co-sponsored by the National Hemophilia Foundation, Postgraduate Institute for Medicine, and Impact Education, LLC. This activity is supported by educational grants from Baxter BioScience, Biogen Idec, Novo Nordisk, Inc., Bayer HealthCare, and CSL Behring.

Hemophilia Pharmacy Management: Steps for Success With Managed Care and Specialty Pharmacy Hot Topics Include: - Clinical Updates in Hemophilia Treatment - Mock Comprehensive Care Team Visit Featuring an Actual Patient - A Patient's Journey through the Care Process of Various Payer Types with Breakout Rotations Workshop 1 - Commercial Plan Workshop 2 - Medicaid Plan Workshop 3 - Medicare Plan Held in conjunction with the National Hemophilia Foundation's 66th Annual Meeting, "Nothing about us without us" Distinguished Faculty Presenters Jeffrey D. Dunn, PharmD, MBA Senior Vice President VRx Pharmacy Services, LLC Margaret Geary, MA, MBA, MPH, LCSW, CCM Clinical Hemophilia Social Worker UMass Memorial Hospital, New England Hemophilia Center Marc Gilgannon, PT Lead Therapist University of Virginia Children's Hospital John Grossomanides, RPh Senior Clinical Pharmacist Advanced Pharmacy Concepts John W. Knispel, MD, CPE, FACOG Regional Medical Director Commercial Products Florida Humana Inc. Patrick Lynch A Patient with Hemophilia Executive Producer, Believe Digi Jennifer Maahs, RN, PNP, MSN Nurse Practitioner Indiana Hemophilia and Thrombosis Center Steven W. Pipe, MD Director, Division of Pediatric Hematology and Oncology Pediatric Medical Director, Hemophilia and Coagulation Disorders Program University of Michigan Who Should Attend? This activity is designed to meet the educational needs of specialty pharmacists, home health pharmacists, health plan pharmacists, managed Medicaid pharmacists, medical directors, and other health care professionals with an interest in the management of patients with hemophilia. Statement of Need/Program Overview Hemophilia is an expensive chronic condition with total annual costs that can average $250,000 or more for severe patients. Optimal outcomes requires a collaborative and coordinated patient experience. The collaborative team can include an insurer, Hemophilia Treatment Center (HTC), and specialty pharmacy. Specialty pharmacy services can support patient adherence to treatment and assist physicians, plans and employers in meeting clinical and/or financial goals. This symposium, joint sponsored by the National Hemophilia Foundation, will emphasize the need for well-coordinated treatment management, the importance of understanding effective ways of using available treatments, and the importance of collaboration among all stakeholders. Educational Objectives After completing this activity, the participant should be better able to: Discuss the impact of hemophilia with and without inhibitors on clinical, economic, and humanistic outcomes Assess current and emerging hemophilia therapies for children and adults, with and without inhibitors Implement the Medical and Scientific Advisory Council (MASAC) Quality of Care Guidelines for the treatment of hemophilia Employ collaborative care strategies and resources, including HTCs, to improve care coordination for health plan patients with hemophilia Recommend hemophilia management policies and protocols to optimize patient outcomes in a managed care and/or specialty pharmacy setting Provide accurate and appropriate counsel as part of the treatment team Agenda Thursday, September 18, 2014 12:00 PM - 5:00 PM Washington Marriot Wardman Park Hotel Room: Washington 4-5 Washington, DC

12:00-12:30 PM Registration and Lunch 12:30-12:40 PM Introduction and Objectives/Opening Comments 12:40-1:10 PM Clinical Updates in Hemophilia Treatment 1:10-1:55 PM Mock Comprehensive Care Team Visit Featuring an Actual Patient 1:55-2:05 PM Moderated Question and Answer Session 2:05-4:30 PM A Patient's Journey through the Care Process of Various Payer Types (Breakout Rotations) Workshop 1 - Commercial Plan Workshop 2 - Medicaid Plan Workshop 3 - Medicare Plan 4:30-5:00 PM Closing Session   - Summary of Key Take-Aways and Work Plans from Breakouts   - Faculty Panel Roundtable Review of Learning Obectives   - Moderate Question and Answer Session   - Post-Activity Assessment and Evaluation

Physician Accreditation Statement This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the National Hemophilia Foundation, Postgraduate Institute for Medicine, and Impact Education, LLC. The Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians. Credit Designation Postgraduate Institute for Medicine designates this live activity for a maximum of 4.5 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Pharmacist Accreditation Statement Postgraduate Institute for Medicine is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Credit Designation Postgraduate Institute for Medicine designates this continuing education activity for 4.5 contact hours (0.45 CEUs) of the Accreditation Council for Pharmacy Education. (Universal Activity Number - 0809-9999-14-176-L01-P) Upon receipt of a completed activity evaluation form, you will receive an email from the Postgraduate Institute for Medicine within 4 weeks with a link and directions to submit your credit to the NABP CPE Monitor Service. Type of Activity: Application

Disclosure of Conflicts of Interest Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. The existence or absence of COI for everyone in a position to control content will be disclosed to participants prior to the start of each activity.

Americans with Disabilities Act Event staff will be glad to assist you with any special needs (ie, physical, dietary, etc). Please contact Impact Education, LLC, prior to the live event at (215) 619-8812. Fee Information No additional fee is required to attend this CPE/CME activity. Note: There is NO FEE for attending this Special Pre-Conference Symposium. However, if you wish to attend the NHF Annual Meeting sessions from September 18th through September 20th, a registration fee is required. Pre-registration will close at 12:00 pm on September 16, 2014. Walk-in registration will be available at the time of the program. If you have any questions, please call (215) 619-8812 or email info@impactedu.net.